Sitemap
Medical science
02/2004 A kick from within – fetal movement counting and the cancelled progress in antenatal care
02/2004 DNA microarrays detect the expression of apoptosis-related genes in preeclamptic placentas
02/2004 Indicated labor induction with vaginal prostaglandin E2 increases the risk of cesarean section even in multiparous women with no previous cesarean section
02/2004 Cervical immunoglobulin A and altered vaginal flora in pregnant women with threatened preter delivery
02/2004 Multiple courses of antenatal corticosteroid therapy in patients with preterm premature rupture of membranes
02/2004 Implication of cord blood myeloperoxidase but of soluble p-selectin levels in preterm deliveries
02/2004 Fetal and early postnatal magnetic resonance imaging – is there a difference?
02/2004 Bone turnover markers and bone strength during the first weeks of life in very low birth weight premature infants
02/2004 The ponderal index in triplets: I. Relationship to small for gestational age neonates
02/2004 The ponderal index in triplets: II. Gestational age-related patterns of neonatal weights and lengths
02/2004 The ponderal index in triplets: III. Association with birth weight discordance
02/2004 The ponderal index in triplets: IV. Relationship with maternal height
02/2004 Intratracheal albumin reduces interleukin-8 in tracheobronchial aspirates in piglets after meconium aspiration
02/2004 The pulmonary paradox in premature infants: in-utero infected lungs do better than those with accelerated maturation
02/2004 Congenital syphilis: unique clinical presentation in three preterm newborns
02/2004 Twin-to-twin transfusion syndrome complicated by spontaneous mid-trimester uterine rupture
02/2004 Persistent pulmonary hypertension in a premature newborn after 16 hours of antenatal indomethacin exposure
02/2004 Current concepts in standardization of cardiac marker immunoassays
02/2004 Collagen, ageing and nutrition
02/2004 Evaluation of a new efficient procedure for single-nucleotide polymorphism genotyping: tetra-primer amplification refractory mutation system-polymerase chain reaction
02/2004 High prevalence of non-HFE gene-associated haemochromatosis in patients from southern Italy
02/2004 Limited usefulness of the PFA-100? for the monitoring of ADP receptor antagonists–in vitro experience
02/2004 Isolation of plasma small-dense low-density lipoprotein using a simple air-driven ultracentrifuge and quantification using immunassay of apolipoprotein B
02/2004 Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods
02/2004 Calcium oxalate crystallization in untreated urine, centrifuged and filtered urine and ultrafiltered urine
02/2004 Matrix effects in clinical immunoassays and the effect of preheating and cooling analytical samples
02/2004 Blood alcohol testing: comparison of the performance obtained with the different methods used in the Belgian external quality assessment schemes
02/2004 Determination of lipase catalytic activity in two reference materials: BCR 693 and BCR 694 by titrimetry at constant pH
02/2004 Evaluation of a new generation of plastic evacuated blood-collection tubes in clinical chemistry, therapeutic drug monitoring, hormone and trace metal analysis
02/2004 Association between the CYP2C9 polymorphism and the drug metabolism phenotype
02/2004 Analytical goals for coagulation tests based on biological variation
02/2004 In vivo total antioxidant capacity: comparison of two different analytical methods
02/2004 Performance evaluation of automated assays for ?-CrossLaps, N-MID-Osteocalcin and intact parathyroid
hormone (BIOROSE Multicenter Study)
02/2004 Evaluation of the blood gas analyzer GEM(r) PREMIER(tm) 3000
02/2004 Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives
02/2004 Regulation of inflammatory responses by activated protein C: the molecular mechanism(s) and therapeutic implications
02/2004 Increased serum maternal levels of the HER2 oncoprotein p105 ectodomain in preeclampsia
02/2004 Determination of urinary glyoxal and methylglyoxal by high-performance liquid chromatography
02/2004 Antioxidants in patients with hyperthyroidism
02/2004 Biochemical diagnosis of impaired left ventricular ejection fraction - comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP)
02/2004 Autoantibodies against oxidized low-density lipoprotein (ox-LDL) and LDL oxidation status
02/2004 Concomitant isolation of protein C inhibitor and unnicked ?2-glycoprotein I
02/2004 Decreased expression of the insulin-like growth factor-I-binding protein-1 (IGFBP-1) phosphoisoform in pre-eclamptic Wharton's jelly and its role in the regulation of collagen biosynthesis
02/2004 Urine albumin excretion in acute ischaemic stroke is related to serum interleukin-6
02/2004 Diagnostic use of cerebral and extracerebral oxysterols
02/2004 Immunoglobulin G Fc? receptor expression on polymorphonuclear cells in bronchoalveolar lavage fluid of HIV-infected and HIV-seronegative patients with bacterial pneumonia
02/2004 The discordance rate, a new concept for combining diagnostic decisions with analytical performance characteristics. 2. Defining analytical goals applied to the diagnosis of type 2 diabetes by blood glucose concentrations
02/2004 Effects of some pre-analytical conditions on the measurement of homocysteine and cysteine in plasma
02/2004 Testing and validating a homogeneous immunometric assay for interference
02/2004 Linearity evaluation of analytical methods that count particles
02/2004 Environmental dichlorodiphenyltrichlorethane or hexachlorobenzene exposure and breast cancer: is there a risk?
02/2004 Analytical performance and method comparison study of the total homocysteine fluorescence polarization immunoassay (FPIA) on the AxSYM analyzer
02/2004 Screening tests for abnormalities of the protein C anticoagulant pathway / Suchteste für Anomalien im antikoagulatorischen Protein C-System
02/2004 APC resistance: What have we learned since 1993? / APC-Resistenz: Was haben wir seit 1993 hinzugelernt?
02/2004 Thrombophiliediagnostik bei Empfängern von Organtransplantaten / Thrombophilia diagnostics in recipients of organ transplants
02/2004 Maternal thrombophilia and obstetric complications / Mütterliche Thrombophilie und geburtshilfliche Komplikationen
02/2004 Das SARS-assoziierte Coronavirus – Die erste Pandemie des 21. Jahrhunderts / The SARS-associated coronavirus – The first pandemic of the 21st century
02/2004 The diagnostic and clinical impact of the genetic variability of the S (surface) gene of hepatitis B virus / Diagnostische und klinische Relevanz der genetischen Variabilität des S- (surface) Gens des Hepatitis B Virus
02/2004 Ein Modell zur Lieferantenbewertung im medizinischen Laboratorium / A Model for the evaluation of suppliers in medical laboratories
02/2004 Qualitätsmanagement in den medizinischen Laboratorien der Schweiz / Quality management in Swiss diagnostic laboratories
02/2004 Die Situation des Qualitätsmanagements in Österreich / Quality Management in Austria
02/2004 Proteolytic degradation of cardiac troponin I does not influence the TOSOH
AIA-PACK cTnI 2G assay, a second generation test for the determination
of troponin I / Der proteolytische Abbau des kardialen Troponin I hat keinen Einfluss auf den TOSOH AIA-PACK
02/2004 Evaluation of total Hepatitis C virus core antigen quantification / Evaluierung eines Tests zur Quantifizierung des Hepatitis C Kern Antigens
03/2004 The structural basis for the pathophysiological relevance of PAI-I in cardiovascular diseases and the development of potential PAI-I inhibitors
03/2004 Plasminogen activator inhibitor-I and tumour growth, invasion, and metastasis
03/2004 Urokinase-type plasminogen activator (uPA) and its inhibitor PAI-I: novel tumor-derived factors with a high prognostic and predictive impact in breast cancer
03/2004 Neuroserpin: a selective inhibitor of tissue-type plasminogen activator in the central nervous system
03/2004 Both lysine-clusters of the NH2-terminal prion-protein fragment PrP23-110 are essential for t-PA mediated plasminogen activation
03/2004 Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model
03/2004 Thrombin activatable fibrinolysis inhibitor (TAFI) and markers of endothelial cell injury in dialyzed patients with diabetic nephropathy
Back
Search
